Infection: Friend or foe to the development of asthma?

European Respiratory Journal

Volumn 18, Issue 5, 2001, Pages 744-747

  Carlsen, K H ^a   Sterk, P J ^a  

^a Res Institute of Paediatric Asthma   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BRONCHOPNEUMONIA; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOLOGY; LOWER RESPIRATORY TRACT INFECTION; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; VIRUS INFECTION;

ASTHMA; BRONCHIOLITIS; HUMANS;

EID: 0035173203     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.00254001     Document Type: Article

References (52)

1. Acute respiratory disease in infancy and childhood. Present understanding and prospects for prevention
2. Acute respiratory infections are the leading cause of death in children in developing countries
3. Asthma prevalence among school children in Norway
4. Asthma and allergy among schoolchildren in a mountainous, dry, non-polluted area in Norway
5. Generational increase of self-reported first attack of asthma in fifteen industrialized countries. European Community Respiratory Health Study (ECRHS)
6. Family size, infection and atopy: The first decade of the "hygiene hypothesis"
7. Infection: Friend or foe in the development of atopy and asthma? The epidemiological evidence
8. Acute bronchiolitis in infancy
9. Respiratory syncytial viral infections in Oslo 1972-1978. II. Clinical and laboratory studies
10. Respiratory syncytial viral infection in infants with congenital heart disease
11. Respiratory syncytial virus infections in children with compromised immune function
12. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: Hospitalization and economic implications of prophylaxis
13. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families
14. Pattern recognition receptors TLR4 and CD414 mediate response to respiratory syncytial virus
15. The relationship between bronchiolitis and allergic asthma
16. The relationship between bronchiolitis and allergic asthma. A prospective study with allergy evaluation
17. Acute bronchiolitis and the asthmatic child
18. Patterns of allergic respiratory disease in children with a past history of bronchiolitis
19. The relationship between proved viral bronchiolitis and subsequent wheezing
20. Outcome for acute bronchitis, bronchiolitis and pneumonia in infancy
21. Acute bronchiolitis in infancy. The relationship to later obstructive airways disease and characterization of infants at risk
22. Characteristics and prognosis of hospital-treated obstructive bronchitis in children aged less than two years
23. Bronchial asthma after early childhood wheezing: A follow-up until 4.5-6 years of age
24. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study
25. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
26. Wheezing at 8 and 13 years: Changing importance of bronchiolitis and passive smoking
27. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study
28. Wheezing bronchitis reinvestigated at the age of 10 years
29. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: A quantitative review
30. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
31. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7
32. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
33. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection
34. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways
35. Respiratory viral infections as promoters of allergic sensitization and asthma development: Lessons from animal models
36. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: Reappraisal of the role of infections and air pollution
37. Allergen recognition in the origin of asthma
38. The bidirectional capacity of bacterial antigens to modulate allergy and asthma
39. Viruses as precipitants of asthmatic attacks in children
40. Bronchiolitis and asthma: Possible common pathogenetic pathways
41. Respiratory virus infections and aeroallergens in acute bronchial asthma
42. Community study of viral infections in exacerbations of asthma in 9-11 year old children
43. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo
44. The major human rhinovirus receptor is ICAM-1
45. The association of Chlamydia pneumoniae infection and reactive airway disease in children
46. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?
47. Asthma, atopy and Chlamydia pneumoniae antibodies in adults
48. Acute exacerbations of asthma in adults: Role of Chlamydia pneumoniae infection
49. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma
50. A link between chronic asthma and chronic infection
51. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection
52. Role of persistent infection in the control and severity of asthma: Focus on Chlamydia pneumoniae